Filing Details

Accession Number:
0001104659-12-047932
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-06 17:29:18
Reporting Period:
2012-07-03
Filing Date:
2012-07-06
Accepted Time:
2012-07-06 17:29:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1491576 Tesaro Inc. TSRO Pharmaceutical Preparations (2834) 272249687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207833 L Arnold Oronsky C/O Tesaro, Inc.
1000 Winter Street, Suite 3300
Waltham MA 02451
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-03 2,627,257 $0.00 2,627,257 No 4 C Indirect See footnote
Common Stock Acquisiton 2012-07-03 444,444 $13.50 3,071,701 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2012-07-03 9,195,402 $0.00 2,627,257 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. The Series B Preferred Stock converted into shares of TESARO, Inc. common stock on a 3.5 for 1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
  2. Reflects a 1-for-3.5 reverse stock split which became effective prior to the closing of the Issuer's initial public offering.
  3. The shares are held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10. The Reporting Person is a managing director of IMP10. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.